⌘K

Login Start Free

Home/Filings/4/0001104659-25-061267

4//SEC Filing

Nolet Chris 4

Accession 0001104659-25-061267

CIK 0001868279other

View on SEC.gov Company Profile

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 7:29 PM ET

Size

5.4 KB

Accession

0001104659-25-061267

Insider Transaction Report

Form 4

Period: 2025-06-18

ArriVent BioPharma, Inc.AVBP

Director

Transactions

Award
Non-Qualified Stock Option (right to buy)
2025-06-18+15,502→ 15,502 total
Exercise: $24.89From: 2026-06-18Exp: 2035-06-17→ Common Stock (15,502 underlying)

Documents

1 file

4
tm2518583-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ArriVent BioPharma, Inc.

CIK 0001868279

Entity typeother

Related Parties

1

filerCIK 0001782814

Filing Metadata

Form type: 4
Filed: Jun 19, 8:00 PM ET
Accepted: Jun 20, 7:29 PM ET
Size: 5.4 KB

View on SEC.gov